3 minNew era in nasopharyngeal cancer: Toripalimab opens doors for immunotherapy.For decades, nasopharyngeal cancer patients facing recurrent or metastatic disease had limited treatment options.
4 minOptimizing Care: Concurrent pembrolizumab with chemoradiation for locally advanced laryngeal cancerIn recent years, the fight against laryngeal cancer has made impressive strides, with cutting-edge treatment modalities altering
3 minLenvatinib plus pembrolizumab improved survival outcomes in advanced endometrial cancerUterine cancer is the second most prevalent Gynecological cancer in the world and it has high incidence rates in developed countries.